{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:09:40Z","timestamp":1791284980724,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs, Department of the Army","doi-asserted-by":"crossref","award":["CDMRP093619"],"award-info":[{"award-number":["CDMRP093619"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P01 AG036675"],"award-info":[{"award-number":["P01 AG036675"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.exger.2013.06.004","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T01:35:10Z","timestamp":1372988110000},"page":"898-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength"],"prefix":"10.1016","volume":"48","author":[{"given":"Phonepasong","family":"Arounleut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bialek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Fang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadanand","family":"Fulzele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elsalanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Isales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Hamrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2013.06.004_bb0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/ip.2010.029579","article-title":"Review of the long-term disability associated with hip fractures","volume":"17","author":"Bertram","year":"2011","journal-title":"Inj. Prev."},{"key":"10.1016\/j.exger.2013.06.004_bb0010","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.bone.2007.12.076","article-title":"Mice treated with a myostatin\/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass","volume":"42","author":"Bialek","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.exger.2013.06.004_bb0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.exger.2013.06.004_bb0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1096\/fj.04-2796com","article-title":"Myostatin-propeptide mediated amelioration of dystrophic pathophysiology","volume":"19","author":"Bogdanovich","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.exger.2013.06.004_bb0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nmd.2009.06.014","article-title":"Preliminary results from single subcutaneous administration of ACE-031, a form of the soluble activin typeII B receptor, in healthy postmenopausal volunteers","volume":"19","author":"Borgstein","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.exger.2013.06.004_bb0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.exger.2012.11.004","article-title":"Effects of the activin A-myostatin\u2013follistatin system on aging bone and muscle progenitor cells","volume":"48","author":"Bowser","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2013.06.004_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glt030","article-title":"Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents","author":"Chiu","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"11","key":"10.1016\/j.exger.2013.06.004_bb9000","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.exger.2013.06.004_bb0040","first-page":"1167","article-title":"Systemic administration of soluble activin receptors produces differential anabolic effects in muscle and bone in mice","author":"Digirolamo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.exger.2013.06.004_bb0045","first-page":"56","article-title":"Myostatin (GDF-8) as a key factor linking muscle mass and bone structure","volume":"10","author":"Elkasrawy","year":"2010","journal-title":"J. Musculoskelet. Neuronal. Interact."},{"key":"10.1016\/j.exger.2013.06.004_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08977194.2011.599324","article-title":"Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression","volume":"29","author":"Elkasrawy","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.exger.2013.06.004_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1369\/0022155411425389","article-title":"Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing","volume":"60","author":"Elkasrawy","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.exger.2013.06.004_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/er.2012-1012","article-title":"The roles of vitamin D in skeletal muscle: form, function and metabolism","volume":"34","author":"Girgis","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.exger.2013.06.004_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1138\/20100423","article-title":"Invited perspective: myostatin (GDF8) as a therapeutic target for the prevention of osteoporotic fractures","volume":"7","author":"Hamrick","year":"2010","journal-title":"IBMS BoneKey."},{"key":"10.1016\/j.exger.2013.06.004_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JES.0b013e318201f601","article-title":"A role for myokines in muscle\u2013bone interactions","volume":"39","author":"Hamrick","year":"2011","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.exger.2013.06.004_bb0075","first-page":"1","article-title":"The skeletal muscle secretome: an emerging player in muscle\u2013bone crosstalk","volume":"60","author":"Hamrick","year":"2012","journal-title":"Nat. Bonekey"},{"key":"10.1016\/j.exger.2013.06.004_bb0080","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bone.2006.04.011","article-title":"Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin","volume":"39","author":"Hamrick","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.exger.2013.06.004_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1359\/JBMR.051203","article-title":"Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise","volume":"21","author":"Hamrick","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.exger.2013.06.004_bb0090","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1359\/jbmr.080213","article-title":"Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight","volume":"23","author":"Hamrick","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.exger.2013.06.004_bb0095","first-page":"64","article-title":"Role of muscle-derived growth factors in bone formation","volume":"10","author":"Hamrick","year":"2010","journal-title":"J. Musculoskelet. Neuronal. Interact."},{"key":"10.1016\/j.exger.2013.06.004_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/TA.0b013e3181c451f4","article-title":"Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury","volume":"69","author":"Hamrick","year":"2010","journal-title":"J. Trauma"},{"key":"10.1016\/j.exger.2013.06.004_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.39428.470752.AD","article-title":"Shifting the focus in fracture prevention from osteoporosis to falls","volume":"336","author":"Jarvinen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.exger.2013.06.004_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbrc.2004.01.085","article-title":"Characterization and identification of the inhibitory domain of GDF-8 propeptide","volume":"315","author":"Jiang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exger.2013.06.004_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bone.2008.08.126","article-title":"Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume","volume":"44","author":"Kellum","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.exger.2013.06.004_bb0120","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice","volume":"64","author":"LeBrasseur","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2013.06.004_bb0125","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2013.06.004_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152210793663810","article-title":"Metabolic functions of myostatin and GDF11","volume":"10","author":"McPherron","year":"2010","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.exger.2013.06.004_bb9005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2011.09.146","article-title":"Differential regulation of the ascorbic acid transporter SVCT2 during development and in response to ascorbic acid depletion","volume":"414","author":"Meredith","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exger.2013.06.004_bb0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1474-9726.2009.00508.x","article-title":"Effects of myostatin deletion in aging mice","volume":"8","author":"Morissette","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2013.06.004_bb0140","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1096\/fj.10-159608","article-title":"Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function","volume":"24","author":"Murphy","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.exger.2013.06.004_bb0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.berh.2010.10.003","article-title":"Osteoporosis and fragility fractures","volume":"24","author":"S\u00e0nchez-Riera","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.exger.2013.06.004_bb0150","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/me.2008-0290","article-title":"Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators","volume":"22","author":"Souza","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.exger.2013.06.004_bb0155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/II trial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.exger.2013.06.004_bb0160","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bone.2010.07.014","article-title":"Effect of whole body vibration on bone properties in aging mice","volume":"47","author":"Wenger","year":"2010","journal-title":"Bone"}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556513002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556513002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T20:30:22Z","timestamp":1539549022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556513002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0531556513002052"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2013.06.004","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2013.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}